Substantial costs and underreporting of dengue fever, concerns about blood supply face USOctober 17, 2007Research to be presented at the 56th Annual American Society of Tropical Medicine and Hygiene Meeting in Philadelphia Dengue fever, known as "breakbone fever" because of the excruciating back and joint pain that accompanies this infectious disease, is a growing public health threat for people living in tropical countries, as well as travelers to destinations such as Thailand, Brazil and Puerto Rico, according to research being presented at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), Nov. 4-7. Protocol Needed to Screen Blood Donors Dengue, which is believed to infect millions of people annually in developing countries, and also causes some infections in Texas along the border of Mexico, is usually transmitted by mosquitoes. A recent study examined the prevalence of dengue virus among blood donors in Puerto Rico and found that one in every 1,300 donors tested positive during the 2005 epidemic, which means that this sometimes fatal disease might be transferred to others through the blood supply. "The frequency of finding dengue virus in blood donors during outbreaks is comparable to what we see with West Nile virus," said Susan Stramer, executive scientific officer, American Red Cross. "However, we still need to better understand transfusion-associated transmission of dengue and the dynamics of the virus in donors." Still, the American Red Cross and public health officials plan to start dengue blood donor screening using a research protocol in Puerto Rico in 2008. Underreporting Remains Public Health Concern Researchers believe that dengue is grossly underreported in many countries. For example, in 2004, 557,000 cases and 1,800 deaths were reported globally to WHO, but the projected dengue burden was more than 8 million cases and nearly 20,000 deaths. In addition to underreporting, the lack of a rapid and accurate diagnostic test, potential misdiagnoses of milder forms of dengue as influenza, as well as limited data further challenge efforts to measure the global burden of this threatening disease. And, with no drugs available to treat dengue, patients' prognosis relies on good medical management, including rest, fluids and pain relief. Direct and Indirect Costs of Dengue In the first comprehensive, multi-country analysis of dengue by all stakeholders (households, employers and public health systems), the new study reveals a substantial epidemiological, social and economic burden associated with the disease. "On average, a hospitalized case of dengue costs three times that of an ambulatory case," said Jose Suaya, scientist at Brandeis University and co-investigator of the study, which was conducted in eight countries across South East Asia and South America from 2005-2006. "An episode of dengue has a tremendous impact on the government, households and employers," said Donald Shepard, professor at Brandeis University and co-investigator of the study. "More attention is needed to understand global patterns of dengue and related costs to develop sound policy and appropriately allocate resources for its prevention and treatment. We believe this data is an important first step." Researchers assessed direct medical costs, non-medical costs and indirect costs (e.g., days lost by patients and caretakers from school, work) and found that even though countries have major public health systems that pay for care, there was a heavy toll on households due to out-of-pocket expenses. For ambulatory patients, families assume most of the burden, and even when someone is hospitalized, they assume about 25% of the related costs. American Society of Tropical Medicine and Hygiene |
|||||||||||||||||||||
| Related Dengue Fever Current Events and Dengue Fever News Articles On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Climate variability and dengue incidence Research published this week in PLoS Medicine demonstrates associations between local rainfall and temperature and cases of dengue fever, which affects an estimated fifty million people per year worldwide. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. Population movement can be critical factor in dengue's spread Human movement is a key factor of dengue virus inflow in Rio de Janeiro, according to results from researchers based at the Oswaldo Cruz Foundation (Fiocruz) in Brazil. UH Manoa researcher examines possible implications of daily commute and mosquito-borne diseases University of Hawaii at Manoa assistant researcher Durrell Kapan recently published a paper, Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics, in PLoS One. Published August 26, the paper highlights how daily commuting patterns in mega-cities may be a critically overlooked factor in understanding the resurgence of mosquito-borne diseases such as dengue fever, infecting 50-100 million people annually. Researchers develop the first climate-based model to predict Dengue fever outbreaks Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are the most important vector-borne viral diseases in the World. Dengue fever costs billions in health care, lost productivity and absenteeism Researchers at Brandeis, in collaboration with several other institutions worldwide, have pinpointed for the first time the multi-country economic costs of dengue fever, the endemic and epidemic mosquito-borne illness that is a rapidly growing public health problem in tropical and sub-tropical countries. Visualizing virus replication in 3 dimensions Dengue fever is the most common infectious disease transmitted by mosquitoes - some 100 million people around the world are infected. Researchers at the Hygiene Institute at Heidelberg University Hospital were the first to present a three-dimensional model of the location in the human cell where the virus is reproduced. La Jolla Institute announces 2.0 launch of major database to aid vaccine development worldwide Key improvements in a major infectious disease database that will aid vaccine development worldwide were unveiled today with the 2.0 launch of the National Institutes of Health-sponsored Immune Epitope Database and Analysis Resource (IEDB). Mosquito parasite may help fight dengue fever Dengue fever is a terrible viral disease blighting many of the world's tropical regions. Carried by mosquitoes, such as Aedes aegypti, 40% of the world's population is believed to be at risk from the infection. More Dengue Fever Current Events and Dengue Fever News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||